TCM
VRTX icon

Traynor Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Traynor Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$5.28M Buy
11,675
+631
+6% +$285K 0.37% 41
2025
Q1 		$5.35M Buy
11,044
+5,282
+92% +$2.56M 0.45% 42
2024
Q4 		$2.32M Buy
5,762
+5,256
+1,039% +$2.12M 0.16% 69
2024
Q3 		$235K Buy
+506
New +$235K 0.01% 194